Novogen Limited KZIA
9.51
(0.27)
(2.76%)
as of 25 Sep
- Market cap
- $111.8M
- P/E
- 0.0×
Follow KZIA
| Dec '25 | Jun '25 | Dec '24 | Jun '24 | Older periods | |
|---|---|---|---|---|---|
| P/E ratio | — | — | — | — |
+8 more quarters Free account |
| EV/Sales | — | — | — | — | |
| EV/FCF | — | — | — | — | |
| Quick Ratio | 2.86 | 0.32 | 0.19 | 0.22 | |
| Current Ratio | 2.87 | 0.35 | 0.21 | 0.24 | |
| Net Debt/EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | |
| Debt/Assets | 0.14% | 6.52% | 0.79% | 2.94% | |
| Debt/Equity | 0.00 | (0.05) | (0.04) | (0.06) | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating CF/Net income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capex/Depreciation | — | 0.00 | 0.00 | 0.00 | |
| Intangible Assets out of Total Assets | 0.02 | 0.18 | 0.81 | 0.71 | |
| Share Based Compensation of Revenue | 0.00% | — | 0.00% | — | |
| Free Cash Flow Yield | — | — | — | — | |
| Operating CF per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capex per Share | — | 0.00 | — | 0.00 | |
| Free Cash Flow per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Shareholders Equity per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Debt per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book value per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | (6.26) | (8.60) | (5.49) | (6.28) | |
| Working Capital | 29.94 | (5.91) | (8.54) | (12.89) | |
| Capital Expenditures | — | 0.00 | — | 0.00 | |
| Net Current Asset Value | 29.76 | (6.11) | (11.93) | (16.69) | |
| EV/EBIT | — | — | — | — | |
| Capex to Sales | — | 0.00 | — | 0.00 | |
| Other line items | |||||
| Average Receivables | 1.32 | 1.34 | 0.27 | 1.31 | |
| Average Payables | 5.12 | 4.73 | 4.44 | 6.30 | |
| Average Assets | 31.28 | 11.42 | 14.99 | 19.76 | |
| Average Common Equity | 16.97 | 1.37 | 2.57 | 3.48 |
Columns are period end dates